Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program (BRIDGE-ADHD)
The present research study will evaluate the feasibility and preliminary efficacy of the adapted Building Regulation in Dual Generations program for families of children (8-12 years old) with Attention-Deficit/Hyperactivity Disorder, creating the BRIDGE-ADHD program. The BRIDGE-ADHD program combines 10 weekly online psycho-education sessions with knowledge about ADHD and relevant parenting skills training videos to improve maternal wellbeing and parenting practices, thus supporting children's own psychological wellbeing through an intergenerational approach. This study will specifically evaluate whether the BRIDGE-ADHD program is able to reduce mothers' psychological distress (e.g., depression, anxiety, parenting stress) and simultaneously reduce their children's attention and/or behaviour problems.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Families of children with attention-deficit/hyperactivity disorder (ADHD) often experience elevated parenting stress. Maternal psychological distress (e.g., symptoms of depression and anxiety) is associated with harsher parenting practices that may increase children's risk for both externalizing and internalizing behaviour problems, including ADHD symptoms such as hyperactivity, impulsivity, and inattention. ADHD is in turn associated with deficits in self-regulation and executive functioning, which tend to result in social and academic difficulties that negatively impact the lives of children and families.
Supporting parents through effective parenting strategies is a key modifiable factor that can reduce child behavioural difficulties. Improving parent mental health by reducing parenting stress through skills-based parenting and psychoeducation may reduce parental distress and improve family functioning.
The Building Regulation in Dual Generations program (BRIDGE) for ADHD program is designed to provide mothers with mental health support and parenting skills that promote more effective management of their child's ADHD symptoms and, ultimately, reduce attention and behaviour problems through improvements in self-regulation. BRIDGE-ADHD is an adapted 10 week program that aims to support intergenerational emotion regulation and positive parenting strategies. The program combines dialectical behaviour therapy (DBT) skills with parenting-focused psychoeducational content. Each week, participants will attend a 1.5 hour synchronous online group session led by a licensed clinical psychologist, co facilitated by clinical psychology graduate students under supervision, and a peer parent coach who has previously participated in the BRIDGE program.
This study will use a non-randomized, parallel-assignment feasibility pilot design to evaluate the feasibility and potential efficacy of BRIDGE-ADHD in addressing parenting stress and children's attentional and behavioural problems. We will recruit thirty parent-child dyads (15 intervention participants and 15 normative controls). Participants in the intervention group will complete the 10 week online BRIDGE-ADHD program and in person assessments at two time points: pre intervention (week 0-1; T0) and post intervention (week 10; T1). The normative control group will complete the same in person assessments without participating in the intervention. The primary aim is to examine the feasibility and acceptability of BRIDGE-ADHD and its impact on maternal mental health and children's social-emotional development.
Secondary aims are to evaluate the program's efficacy in reducing parenting stress and decreasing harsh parenting tendencies. Exploratory aims include examining differences or changes in sleep quality, mental well-being, relationships, and child academic achievement before and after participation in BRIDGE-ADHD.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Tasmia Hai, PhD
- Telefonnummer: 14166609291
- E-mail: tasmia.hai@umanitoba.ca
Studiesteder
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3T 2N2
- University of Manitoba
-
Kontakt:
- Tasmia Hai, PhD
- Telefonnummer: 4166609291
- E-mail: tasmia.hai@umanitoba.ca
-
Kontakt:
- E-mail: tasmia.hai@umanitoba.ca
-
Ledende efterforsker:
- Tasmia Hai, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Mothers must be 18 years old or older with both current and elevated symptoms of depression (T-score > 5 on the PHQ-9).
- Mothers must have a child between the ages of 8 and 12 years old.
- Both mothers and children must currently live in Manitoba.
- Mothers must self-report that their child has a diagnosis of ADHD. This will be confirmed by having mothers complete the CBCL (T-score > 65) and through intake interviews with clinicians.
- Both mothers and children must speak fluent English.
- Mothers must have neither attempted suicide within the past year nor self-harmed resulting in an injury that either did or should have received medical attention within the past 6 months.
Exclusion Criteria:
- not meeting the listed criteria above
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: BRIDGE-ADHD
The group that will receive the BRIDGE-ADHD program |
The BRIDGE-ADHD program is a 10-week program that combines online psychoeducation sessions with parenting manual handouts and parenting skills training videos to improve maternal wellbeing and promote positive parenting practices tailored to the needs of families of children with ADHD. The BRIDGE-ADHD program content is largely based on mindfulness and dialectical behaviour therapy (DBT) skills, including emotion regulation, distress tolerance, and other related skills. The program will also include psycho-education on ADHD and parenting skills |
|
Ingen indgriben: Normative Control
This is a normative control group who will not be receiving any intervention. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in child mental health symptoms following BRIDGE-ADHD intervention
Tidsramme: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
|
Changes in child mental health symptoms will be measured using the Child Behavior Checklist (CBCL) for ages 6 to 18. The CBCL is a 100-item parent-report questionnaire with a range of scores from 0 to 200, measuring child functioning across externalizing and internalizing symptoms. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores indicate greater symptom severity. We will use the CBCL to assess a) total behaviour problems, b) ADHD subscale scores, c) internalizing behaviours, and d) externalizing behaviours. These subscale scores will collectively be investigated as child mental health symptoms. |
This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal depressive symptoms
Tidsramme: This measure will be administered at baseline, which is considered week 0-1 (noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention taking place at weeks 11-12 ( noted as T1).
|
Depressive symptoms will be measured using the Patient Health Questionnaire 9-Item (PHQ-9). The PHQ-9 is a 9-item self-report questionnaire with a range of scores from 0 to 27. Higher scores indicate greater symptom severity. |
This measure will be administered at baseline, which is considered week 0-1 (noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention taking place at weeks 11-12 ( noted as T1).
|
|
Maternal ratings of program acceptability
Tidsramme: This measure will be administered after the 10 week of BRIDGE intervention, post-intervention (noted as T1) expected to take place sometime between weeks 11-12.
|
Maternal ratings of program acceptability will be collected using an open-ended program acceptability questionnaire developed by the research team. Participants will rate how important various components of the program were to them and will be asked to respond to open-ended questions regarding their experience in the program. |
This measure will be administered after the 10 week of BRIDGE intervention, post-intervention (noted as T1) expected to take place sometime between weeks 11-12.
|
|
Recruitment Feasibility Metrics
Tidsramme: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
The feasibility of the BRIDGE-ADHD program will be evaluated using a range of implementation metrics. Recruitment feasibility will be assessed by examining eligibility rates, enrollment rates, and the time required to recruit the target sample. All of these measures will be presented in rates allowing for common measurement across domains. |
These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
|
Data Collection Feasibility
Tidsramme: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
The feasibility of the BRIDGE-ADHD program will be evaluated using a range of implementation metrics. Data collection feasibility will be determined by the proportion of participants completing baseline and post-intervention assessments, rates of missing data, and the time required to complete study measures. |
These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
|
Program Implementation Outcomes
Tidsramme: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
Program implementation outcomes, including session attendance, reasons for missed sessions or withdrawal, scheduling challenges, technological issues and facilitator reflections on program delivery |
These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
|
Program Retention Measure
Tidsramme: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
Retention and adherence will be measured by the proportion of participants who complete the program, attendance rates across the 10 sessions, and watching home videos, where applicable. |
These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in parent ratings of child behaviours
Tidsramme: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
|
Changes in parent ratings of child behaviours will be measured using the Behaviour Assessment System for Children - Third Edition (BASC-3). The BASC-3 is a parent-report questionnaire measuring externalizing and internalizing problems, attention problems, school problems, as well as adaptive strengths like social skills and study skills. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores on problem factors indicate more severe problems. Higher T-scores on strengths indicate more of those strengths. We will be specifically looking at broader subscale scores to identify if there has been any change in child behaviours. |
This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
|
|
Changes in Parenting stress
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Parenting stress will be measured using the Parenting Stress Index Short Form (PSI-SF). The PSI-SF is a self-report questionnaire requiring respondents to answer questions regarding their overall experience of parenting stress using a 5-point Likert with a range of scores range from 36 to 180. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores indicate higher levels of parenting stress. Changes in total parenting stress score will be measured. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in difficulties with maternal emotion regulation
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in difficulties with emotion regulation will be measured using the Difficulties in Emotion Regulation 36-Item Scale (DERS-36). The DERS-36 is a self-report questionnaire assessing emotion dysregulation across 6 dimensions, including nonacceptance of emotions, difficulties with goal-directed behaviour, impulse control, lack of emotional awareness, limited access to regulation strategies, and lack of emotional clarity. Respondents rate often each statement describes them on a 5-point Likert scale with higher scores indicating greater difficulties. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Total scores range from 36 to 180 with higher score indicating greater overall difficulties with emotion regulation. Changes in total emotion regulation T-score will be measured. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal feelings of anger
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in anger will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Anger subscale. The PROMIS Anger subscale contains 5 items with a range of scores from 5 to 25. Higher scores indicate higher levels of anger. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal sleep problems
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in maternal sleep disturbances will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance subscale short form. The subscale contains 8 items with a range of scores from 8 to 40. Higher scores indicate greater sleep disturbance severity. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in children's sleep habits
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in children's sleep habits will be measured using the Children's Sleep Habits Questionnaire (CSHQ). The CSHQ is a 45-item parent-report questionnaire assessing common sleep problems in children aged 4 to 12, including bedtime resistance and night waking. Higher scores indicate more severe sleep problems with scores above 41 suggesting clinical concerns. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal anxiety symptoms
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Anxiety symptoms will be measured using the Generalized Anxiety Disorder 7-Item Scale (GAD-7). The GAD-7 contains 7 items with a range of scores from 0 to 21. Higher scores indicate higher levels of anxiety symptoms. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal Attention and Hyperactivity symptoms
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in maternal ADHD symptoms will be measured using the Adult ADHD Self-Report Scale (ASRS). The ASRS is an 18-item questionnaire screening for ADHD symptoms in adults based on DSM criteria. Part A of the scale contains 6 items screening for the most predictive symptoms and Part B collects additional details. Total scores range from 0 to 72 with higher scores indicating greater frequency and severity of ADHD symptoms. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Measure of Child health
Tidsramme: This measure will be administered at baseline (noted as T0), expected to occur sometime between weeks 0-1.
|
Child health will be assessed using a parent-report questionnaire developed by the research team. Parents will be asked to respond to questions about their child's physical and mental health from birth to the present. |
This measure will be administered at baseline (noted as T0), expected to occur sometime between weeks 0-1.
|
|
Changes in harsh parenting
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in harsh parenting will be measured using the Behaviour Assessment System for Children - Third Edition (BASC-3) Parenting Relationship Questionnaire. The BASC-3 is an 87-item parent-report questionnaire for children aged 2 to 18 years with 7 parenting behaviour subscales, including communication and involvement. Higher scores indicate more of the relevant subscale. Specifically, change in harsh parenting will be measured. All raw scores are converted into T-scores across all domains tested to have standardized outcomes. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in parent report measures of child executive function skills
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in child executive function skills will be measured using the Behavior Rating Inventory of Executive Function - Second Edition (BRIEF-2). The BRIEF-2 is a 63-item parent-report questionnaire with 9 subscales, including inhibition, working memory, emotion control, and other clinically relevant subscales. Higher scores on each subscale indicate more of the relevant executive function skill. All raw scores are converted into T-scores across all domains tested to have standardized outcomes. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in academic achievement
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in academic achievement will be measured using the Weschler Individual Achievement Test - Fourth Edition (WIAT-4). The WIAT-4 is an individually administered assessment for ages 4 to 50 measuring 4 key areas of academic achievement, including mathematics, reading, written expression, and oral language. Each of these areas contain several relevant subtests. Raw scores on the WIAT-4 are converted into both percentile ranks and composite subtest scores. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in knowledge, pattern recognition, and problem solving
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in knowledge, pattern recognition, and problem solving will be measured using the Weschler Abbreviated Scale of Intelligence - Second Edition (WASI-II). The WASI-II is a standardized intelligence test for ages 6 to 90 with verbal and nonverbal subtests assessing various aspects of overall cognitive ability. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in child core attention skills
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in attention will be measured using the Continuous Performance Test - Third Edition (CPT-3). The CPT-3 is a computerized task measure for individuals aged 8 years or older assessing 4 key components, including inattention, sustained attention, impulsivity, and vigilance. During the task participants are instructed to respond to visual stimuli but ignore other visual stimuli. Performance is based on the number of commissions, omissions, perseverations, hit reaction time, detectability, and other factors. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in child inhibition skills
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in inhibition will be measured using the Neurodevelopmental Assessment for Children - Second Edition (NEPSY-II). The inhibition subtest for ages 5 to 16 assesses impulse control and other components of executive functioning with scaled scores ranging from 1 to19. Higher scores on the inhibition subtest indicate greater response inhibition. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal perceived social support
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in maternal perceived social support from family, friends, and significant others will be measured using the Multidimensional Scale of Perceived Social Support. Total scores range from 12 to 84 with higher scores indicating higher levels of perceived social support. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Service use
Tidsramme: This measure will be administered at baseline (noted as T0), expected to occur before the beginning of the intervention
|
Service use will be measured using a service use questionnaire developed by the research team. Participants will be asked questions regarding their interactions with police, child and family services, medical services, and community organizations during the past 1 year. |
This measure will be administered at baseline (noted as T0), expected to occur before the beginning of the intervention
|
|
Changes in maternal cannabis use
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in maternal cannabis use will be measured using the Cannabis Use Disorder Identification Test (CUDIT). The CUDIT contains 8 items with a range of scores from 0 to 32. Higher scores indicate more hazardous cannabis use. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in maternal alcohol use
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in maternal alcohol use will be measured using the Alcohol Use Disorder Identification Test (AUDIT). The AUDIT contains 10 items with a range of scores from 10 to 40. Higher scores indicate more hazardous or harmful alcohol use. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in recent Stressful Experiences
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
The Recent Stressful Experiences (RSE) checklist was developed according to the recommendations of the JBP Research Network on Toxic Stress from the Center on the Developing Child at Harvard University. The RSE measures familial exposure to various stressors and contains 2 items that ask about stressors which participants may have experienced. Each of these items has a range of scores from 0 to 10 with higher scores indicating more stressful experiences. The RSE also contains 5 items measuring participants' ability to cope with stressful life events. Scores on these 5 items range from 4 to 21 with higher scores indicating a greater ability to cope with stress. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
|
Changes in child affection recognition
Tidsramme: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Changes in affect recognition will be measured using the Neurodevelopmental Assessment for Children - Second Edition (NEPSY-II). The affect recognition subtest assesses social perception with scaled scores ranging from 1 to 19. Higher scores on the affect recognition subtest indicate greater ability to identify and discriminate between emotions. |
This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Publikationer og nyttige links
Generelle publikationer
- Roos LE, Kaminski L, Stienwandt S, Hunter S, Giuliano R, Mota N, Katz LY, Zalewski M. The Building Regulation in Dual-Generations Program (BRIDGE): A Mixed-Methods Feasibility Pilot of a Parenting Program for Depressed Mothers of Preschoolers, Matched with Dialectical Behavior Therapy Skills. Child Psychiatry Hum Dev. 2023 Feb;54(1):34-50. doi: 10.1007/s10578-021-01219-1. Epub 2021 Aug 4.
- Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019 Oct;144(4):e20192528. doi: 10.1542/peds.2019-2528.
- Theule, J., Wiener, J., Tannock, R., & Jenkins, J. M. (2010). Parenting stress in families of children with ADHD: A meta-analysis. Journal of Emotional and Behavioral Disorders, 21(1), 3-17. https://doi.org/10.1177/1063426610387433
- Pinquart M. Associations of parenting dimensions and styles with externalizing problems of children and adolescents: An updated meta-analysis. Dev Psychol. 2017 May;53(5):873-932. doi: 10.1037/dev0000295.
- Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, Cameron EE, Giuliano R, Katz LY, Kelly LE, Letourneau N, Mota N, Reynolds K, Zalewski M, Pharazyn A, Roos LE. Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE): preventing the intergenerational transmission of mental illness in at-risk preschool children. Trials. 2023 Sep 19;24(1):597. doi: 10.1186/s13063-023-07591-8.
- Mingebach T, Kamp-Becker I, Christiansen H, Weber L. Meta-meta-analysis on the effectiveness of parent-based interventions for the treatment of child externalizing behavior problems. PLoS One. 2018 Sep 26;13(9):e0202855. doi: 10.1371/journal.pone.0202855. eCollection 2018.
- Hong Y, Bertrand CM, Deater-Deckard K, Smith CL, Bell MA. The role of mother's and child's self-regulation on bidirectional links between harsh parenting and child externalizing problems. Dev Psychol. 2024 Mar;60(3):441-455. doi: 10.1037/dev0001661. Epub 2024 Jan 22.
- Heard, H. L., & Linehan, M. M. (1994). Dialectical behavior therapy: An integrative approach to the treatment of borderline personality disorder. Journal of Psychotherapy Integration, 4(1), 55-82. https://doi.org/10.1037/h0101147
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- HE2026-0071
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Given the sensitive nature of the data, we have not decided whether the data can be shared or not.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .